Loraz and Noroxin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Noroxin (norfloxacin). Common drug interactions include fear among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Noroxin. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Noroxin?

Noroxin has active ingredients of norfloxacin. It is often used in urinary tract infection. eHealthMe is studying from 1,675 Noroxin users. Check the latest studies of Noroxin.

On Jul, 07, 2026

14 people who take Loraz and Noroxin together, and have interactions are studied.

What are the common drug interactions of Loraz and Noroxin, by gender? *:

female:

Fear
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
General physical health deterioration (weak health status)
Haemoglobin decreased
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Renal failure (kidney dysfunction)
Chronic kidney disease
Hyperkalaemia (damage to or disease of the kidney)
Pyrexia (fever)
Renal failure chronic (long lasting kidney dysfunction)

male:

Anaemia (lack of blood)
Asthenia (weakness)
Stupor (lack of critical cognitive function and level of consciousness)
Drug toxicity
Dyspnoea (difficult or laboured respiration)
Fall
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Oedema peripheral (superficial swelling)

What are the common drug interactions of Loraz and Noroxin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chronic kidney disease
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haemoglobin decreased
Renal failure (kidney dysfunction)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)

50-59:

Fall
Fear
Sleep disorder
Somnolence (a state of near-sleep, a strong desire for sleep)
Stupor (lack of critical cognitive function and level of consciousness)
Abnormal behaviour
Agitation (state of anxiety or nervous excitement)
Brain damage
Cerebral atrophy (decrement in size of brain)
Confusional state

60+:

Hyperkalaemia (damage to or disease of the kidney)
Pyrexia (fever)
Back pain
Blood creatinine increased
Blood urea increased
Cardiac murmur (an heart sound in valve abnormality)
Cardiomegaly (increased size of heart than normal)
Cellulitis (infection under the skin)
Chills (felling of cold)
Constipation

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 42.86%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 28.57%
Depression: 4 people, 28.57%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 21.43%
Sleep Disorder: 3 people, 21.43%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 21.43%
Pain: 3 people, 21.43%
Gout (uric acid crystals building up in the body): 3 people, 21.43%
Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 21.43%
Allergies: 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Noroxin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously